Clofibric acid stimulates branched-chain amino acid catabolism by three mechanisms

Rumi Kobayashi, Taro Murakami, Mariko Obayashi, Naoya Nakai, Jerzy Jaskiewicz, Yoko Fujiwara, Yoshiharu Shimomura, Robert A. Harris

Research output: Contribution to journalArticle

47 Scopus citations

Abstract

Clofibrate promotes catabolism of branched-chain amino acids by increasing the activity of the branched-chain α-keto acid dehydrogenase [BCKDH] complex. Depending upon the sex of the rats, nutritional state, and tissue being studied, clofibrate can affect BCKDH complex activity by three different mechanisms. First, by directly inhibiting BCKDH kinase activity, clofibrate can increase the proportion of the BCKDH complex in the active, dephosphorylated state. This occurs in situations in which the BCKDH complex is largely inactive due to phosphorylation, e.g., in the skeletal muscle of chow-fed rats or in the liver of female rats late in the light cycle. Second, by increasing the levels at which the enzyme components of the BCKDH complex are expressed, clofibrate can increase the total enzymatic activity of the BCKDH complex. This is readily demonstrated in livers of rats fed a low-protein diet, a nutritional condition that induces a decrease in the level of expression of the BCKDH complex. Third, by decreasing the amount of BCKDH kinase expressed and therefore its activity, clofibrate induces an increase in the percentage of the BCKDH complex in the active, dephosphorylated state. This occurs in the livers of rats fed a low-protein diet, a nutritional condition that causes inactivation of the BCKDH complex due to upregulation of the amount of BCKDH kinase. WY-14,643, which, like clofibric acid, is a ligand for the peroxisome-proliferator-activated receptor α [PPARα], does not directly inhibit BCKDH kinase but produces the same long-term effects as clofibrate on expression of the BCKDH complex and its kinase. Thus, clofibrate is unique in its capacity to stimulate BCAA oxidation through inhibition of BCKDH kinase activity, whereas PPARα activators in general promote BCAA oxidation by increasing expression of components of the BCKDH complex and decreasing expression of the BCKDH kinase.

Original languageEnglish (US)
Pages (from-to)231-240
Number of pages10
JournalArchives of Biochemistry and Biophysics
Volume407
Issue number2
DOIs
StatePublished - Jan 1 2002

    Fingerprint

Keywords

  • Branched-chain α-keto acid dehydrogenase complex
  • Branched-chain α-keto acid dehydrogenase kinase
  • Branched-chain amino acids
  • Clofibrate
  • Clofibric acid
  • Liver
  • PPARα
  • Rat
  • WY-14,643

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Kobayashi, R., Murakami, T., Obayashi, M., Nakai, N., Jaskiewicz, J., Fujiwara, Y., Shimomura, Y., & Harris, R. A. (2002). Clofibric acid stimulates branched-chain amino acid catabolism by three mechanisms. Archives of Biochemistry and Biophysics, 407(2), 231-240. https://doi.org/10.1016/S0003-9861(02)00472-1